Nika Pharmaceuticals, Inc. (NIKA)

Nika Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	0	0	0.02	0	0
Cash & Short-Term Investments	0	0	0	0.02	0	0
Cash Growth	-92.01%	-9.31%	-89.37%	2168.06%	116.54%	-75.23%
Prepaid Expenses	0.02	0.02	0.02	-	-	-
Total Current Assets	0.02	0.02	0.02	0.02	0	0
Total Assets	0.02	0.02	0.02	0.02	0	0
Short-Term Debt	0.33	0.32	0.24	0.1	0.02	-
Other Current Liabilities	-	-	-	-	-	0.01
Total Current Liabilities	0.33	0.32	0.24	0.1	0.02	0.01
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	0.33	0.32	0.24	0.1	0.02	0.02
Common Stock	0.1	0.1	0.1	0.09	0.09	0.04
Additional Paid-In Capital	8.6	8.6	8.6	3.23	3.23	0.09
Retained Earnings	-9.02	-9	-8.93	-3.4	-3.34	-0.15
Total Common Equity	-0.31	-0.3	-0.22	-0.08	-0.02	-0.02
Shareholders' Equity	-0.31	-0.3	-0.22	-0.08	-0.02	-0.02
Total Liabilities & Equity	0.02	0.02	0.02	0.02	0	0
Total Debt	0.33	0.32	0.24	0.1	0.02	-
Net Cash (Debt)	-0.33	-0.32	-0.24	-0.08	-0.02	0
Net Cash Growth	-	-	-	-	-	-75.23%
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-
Filing Date Shares Outstanding	1,049	1,048	1,026	876.09	876.09	396.09
Total Common Shares Outstanding	1,049	1,048	1,019	876.09	876.09	396.09
Working Capital	-0.31	-0.3	-0.22	-0.08	-0.02	-0.01
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-0.31	-0.3	-0.22	-0.08	-0.02	-0.02
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.